Texas A&M study links excess RNA to cellular energy loss

Bottom line

Texas A&M researchers say excess RNA buildup inside infected cells can impair mitochondria, reducing the cell’s ability to make energy and potentially worsening the stress of viral infection. In a university news release, the team said the work, published in the Proceedings of the National Academy of Sciences, links RNA accumulation to mitochondrial dysfunction and raises broader questions for viral disease, aging-related conditions, and the design of RNA-based medicines. More broadly, recent literature continues to show that viral infections can disrupt mitochondrial respiration and cellular energetics, reinforcing the biologic plausibility of the finding. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, the study adds mechanistic context to a familiar clinical reality: viral disease can have systemic effects that extend well beyond direct tissue injury. If excess RNA itself contributes to mitochondrial stress and reduced energy production, that could shape how researchers think about pathogenesis, host response, and eventually the safety testing of RNA-based therapeutics used in animal health. It also fits with a growing body of virology research showing that mitochondria are active participants in antiviral signaling and metabolic adaptation during infection. (pubmed.ncbi.nlm.nih.gov)

What to watch: Whether the full PNAS paper prompts follow-up work in animal models, especially around viral pathogenesis and the preclinical evaluation of RNA-platform therapeutics. (pubmed.ncbi.nlm.nih.gov)

Key facts

Institution
Texas A&M
Finding
Excess RNA buildup in infected cells can impair mitochondrial function.
Effect
Reduced ability to generate energy.
Context
Observed during viral infection.
Publication
Proceedings of the National Academy of Sciences
Broader relevance
Viral disease, aging-related conditions, and RNA-based medicines.
Veterinary relevance
Could affect safety testing of RNA-based therapeutics used in animal health.

A Texas A&M study highlighted this week says cells can, in effect, become energy-starved when too much RNA accumulates during viral infection. According to the university’s summary, the work, published in Proceedings of the National Academy of Sciences, found that excess RNA can interfere with mitochondrial function, reducing a cell’s ability to generate energy and expanding the implications of RNA biology beyond simple gene expression or viral replication. (pubmed.ncbi.nlm.nih.gov)

That idea lands in a research area that has been building for years. Mitochondria are now understood not just as the cell’s energy source, but also as a hub for antiviral signaling, inflammation, and stress responses. Reviews in the virology literature describe how RNA viruses can alter mitochondrial dynamics, membrane potential, respiration, and innate immune pathways, often to support replication or evade host defenses. (pubmed.ncbi.nlm.nih.gov)

Texas A&M’s framing is notable because it points to RNA accumulation itself as a driver of mitochondrial dysfunction. In the school’s description, the findings have potential relevance not only for viral infections, but also for aging-related diseases and the safety profile of RNA-based therapeutics and vaccines. That broader reach matters because RNA platforms are increasingly important in both human and animal health research, including vaccine development and other nucleic acid-based interventions. (vetmed.tamu.edu)

While I wasn’t able to verify the exact PNAS manuscript text from the source materials available in search, adjacent newly published research supports the larger biologic theme that RNA handling at mitochondria can materially affect infection outcomes. For example, a 2026 Nature Communications paper reported that viral RNAs can be synthesized at mitochondria/endoplasmic reticulum contact sites and that a mitochondrial nuclease, ENDOG, can act as an antiviral factor by degrading viral RNA. That study is not the Texas A&M paper, but it underscores how closely mitochondrial biology and RNA burden are linked during infection. (pubmed.ncbi.nlm.nih.gov)

I did not find clear outside expert quotes reacting specifically to the Texas A&M study. Still, the surrounding literature reflects strong interest in mitochondria as both sensors and targets during RNA virus infection. Researchers have described mitochondrial-associated membranes as key sites where viral RNA sensing connects to MAVS signaling, and other recent work has explored mitochondria-targeted antiviral strategies. Taken together, that suggests the Texas A&M findings will likely be read as part of a larger shift toward metabolism-aware infectious disease research. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is less about an immediate practice change and more about sharpening the biologic framework behind infectious disease, inflammation, and therapeutic development. In companion animal, livestock, and comparative medicine settings, mitochondrial dysfunction could help explain why some viral infections produce outsized systemic weakness, poor recovery, or tissue-specific injury. It also adds another lens for evaluating RNA-platform products as those technologies expand in veterinary medicine: not just whether they generate the intended immune response, but how cells manage RNA load and metabolic stress. (vetmed.tamu.edu)

The study may also resonate with translational and One Health researchers. Texas A&M’s own veterinary and biomedical programs have been active in coronavirus, deer SARS-CoV-2, and other cross-species infection research, so a mechanistic finding about RNA burden and cell energetics could have relevance across species and model systems. That doesn’t mean the new work changes current clinical guidance, but it could influence how future antiviral strategies and RNA-based biologics are designed and tested. (vetmed.tamu.edu)

What to watch: The next step is the full paper’s uptake by the field: confirmation in animal models, definition of which RNA species and thresholds cause mitochondrial stress, and whether the findings affect preclinical expectations for RNA therapeutics in veterinary and comparative medicine. (pubmed.ncbi.nlm.nih.gov)

Like what you're reading?

The Feed delivers veterinary news every weekday.